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Implantation within the fibrous tissue of a cesarean
scar is considered to be the rarest form of ectopic preg-
nancy, and it constitutes a life-threatening condition
[1,2]. It comprises 6.1% of all ectopic pregnancies in
cases with a history of at least one cesarean delivery [3].
The clinical presentation varies from light and painless
vaginal bleeding to moderate abdominal pain [4]. Many
asymptomatic pregnancies may still be easily misdiag-
nosed, leading to uterine curettage, followed by massive
hemorrhage and emergency hysterectomy [5]. Although
there are several interventions, such as dilatation and
curettage (D&C) under ultrasound guidance, local or
systemic injection of methotrexate (MTX), hysteroscopic
removal of the ectopic pregnancy, uterine artery emboli-
zation, laparotomy or laparoscopic excision, currently
used for maintaining uterine integrity, none have been
universally accepted or found to be completely reliable
[1,2,6–8,10,11,12,13]. Here, we present our experience
in the management of a case of cesarean scar ectopic
pregnancy.
A 40-year-old, gravida 3, para 1, woman presented
to our hospital with vaginal bleeding and noncramp-
ing pain following D&C for inevitable abortion at
another hospital. Her obstetrics history revealed one
lower transverse cesarean section performed 2 years
previously because of fetal death in utero at 37 weeks of
gestation and two D&Cs after the cesarean section.
She had suffered massive vaginal bleeding that required
blood transfusion during and after that procedure. She
was required to stay at that hospital for 3 days. After she
was discharged, she had intermittent vaginal bleeding
until the second postoperative week. On transvaginal
Doppler ultrasonographic examination at our hospital,
a solid tumor 5 × 6 cm in diameter was observed in the
lower part of the uterine cavity, extending from the
anterior cervicoisthmic region of the uterus to the blad-
der (Figure 1A). Magnetic resonance imaging revealed
a 60 × 56 mm bulging mass with a smooth surface and
heterogeneous signal intensity, which had a heteroge-
neous contrast pattern after injection of contrast solu-
tion in the cervicoisthmic region of the uterus (Figure 1B).
The result of a human chorionic gonadotropin (hCG)
test showed a level of 68 mIU/mL. These results led to
the suspected diagnosis of cesarean scar pregnancy.
As the patient had no living child, we administered
75 mg of MTX (1 mg/kg) intramuscularly to preserve
future fertility. One week later, β-hCG levels were
48 mIU/L. A second dose of 75 mg of MTX was admin-
istered intramuscularly. β-hCG levels were 14 mIU/L
and < 5 mIU/L, 1 week and 2 weeks later, respectively.
Although β-hCG levels decreased, the tumor persisted
on transvaginal Doppler ultrasonographic examination.
Minilaparotomy was then performed. No blood was
found in the abdominal cavity. Frozen pathology led
to the diagnosis of cesarean scar pregnancy. Wedge
resection of the ectopic pregnancy was carried out, and
the uterus was preserved for future fertility (Figure 2).
A microscopic examination of the mass confirmed the
diagnosis of cesarean scar pregnancy (Figure 3). The
patient was discharged on the third postoperative day
after an uneventful recovery. Six weeks later, ultrasono-
graphic examination showed a normal uterus.
Cesarean scar pregnancy may carry a high risk of
uncontrollable bleeding requiring hysterectomy, because
the defective myometrium and uterine cervix are less
capable of fibromuscular contraction to control the
bleeding [3,9]. Gestational age and viability, evidence of
myometrial deficiency, the woman’s wish to preserve
fertility and clinical symptoms at presentation are con-
sidered to determine management [3,6,10].
The present case was challenging as the diagnosis
was not straightforward. The patient was initially misdi-
agnosed for inevitable abortion because of the profound
bleeding and had undergone D&C at another hospital.
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Figure 1. (A) Ultrasonographic evaluation of the mass. (B) Magnetic resonance image shows the location of the mass (arrow).
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Figure 2. (A) A wedge resection made through the cervicoisthmic region. (B) The appearance of the uterus after complete
revision.
Figure 3. Necrotic chorionic villi in the fibrous mass (hema-
toxylin and eosin, 200×).
She had massive bleeding, which required blood trans-
fusion during and after the procedure. Implantation in
the uterine scar can cause serious bleeding after an
otherwise uncomplicated dilatation and evacuation
procedures [5,14]. D&C has been shown to be compli-
cated by severe hemorrhage in 76.1% of the patients
undergoing this procedure [4]. Magnetic resonance
imaging and vaginal sonography are also used as a
diagnostic procedure [15].
Conservative treatment of cesarean scar pregnancy
with local and systemically administered MTX has
been reported recently [15–18]. These conservative
treatments avoid unnecessary laparotomy and pre-
serve the patient’s fertility. Lai et al [16] and Lam et al
[14] reported cases of cesarean scar pregnancy treated
with MTX that required laparotomy because of exces-
sive bleeding. Deb et al [19] have described a patient
treated by MTX because of cesarean scar pregnancy.
Despite rapid normalization of serum β-hCG levels,
the patient remained symptomatic and the ultrasound
appearance suggested incomplete trophoblast resorp-
tion. Surgical intervention had to be carried out. In 
the present case, MTX was administered intramus-
cularly as the patient wanted to preserve her fertility.
β-hCG levels were decreased and normalized after the
second treatment of MTX, but the mass persisted on
ultrasound examination and laparotomy had to be
performed as in the case of Deb et al [19].
Since all MTX treatment failures require surgical
intervention to remove the gestational tissue and con-
trol the massive bleeding, most clinicians believe that
primary surgical treatment by laparoscopy, laparo-
tomy and hysterotomy immediately upon confirma-
tion of the diagnosis of cesarean scar pregnancy is the
best option. Laparotomy has, in most cases, become
the first choice for surgeons who have no training in 
or have no adequate equipment for complex laparo-
scopic procedures; however, it requires a larger surgi-
cal wound, longer hospitalization, and longer recovery
time.
In the present case, we performed minilaparotomic
wedge resection of the ectopic mass. Laparotomic wedge
resection of ectopic pregnancy is one of the preferred
management for women wishing to preserve fertility. 
It avoids residual trophoblasts being left in situ and re-
moves the microtubular tracts, and therefore, reduces
the risk of recurrence [3].
In conclusion, obstetricians should not rule out
cesarean scar ectopic pregnancy in patients with a pre-
vious cesarean scar presenting with massive bleeding
during or after D&C, as the incidence of cesarean scar
ectopic pregnancy operations has increased as a result
of the increase in cesarean deliveries.
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